MannKind Corporation (Nasdaq: MNKD) and BIOMM SAannounced the submission of a registration dossier to ANVISA, seeking the approval of Afrezza® ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE